Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression-Reference-Cited by-同舟云学术

Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression

Published:2023-05-01 Issue:9 Volume:133 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Wang Xiaobo,Huang Jing,Liu Fenglin,Yu Qian,Wang Ruina,Wang Jiaqi,Zhu Zewen,Yu Juan,Hou Jun,Shim Joong Sup^ORCID,Jiang Wei,Li Zengxia,Zhang Yuanyuan,Dang Yongjun

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/161929/files/pdf

Reference49 articles.

1. Aurora-A: the maker and breaker of spindle poles

2. Alisertib: a review of pharmacokinetics, efficacy and toxicity in patients with hematologic malignancies and solid tumors

3. An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor

4. Aurora kinase inhibitors: current status and outlook;Bavetsias;Front Oncol,2015

5. Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints;Cancers;2024-08-09

2. Oncoproteins E6 and E7 upregulate topoisomerase I to activate the cGAS-PD-L1 pathway in cervical cancer development;Frontiers in Pharmacology;2024-08-02

3. Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma;Cells;2024-07-06

4. Aurora kinase A inhibition plus Tumor Treating Fields suppress glioma cell proliferation in a cilium-independent manner;Translational Oncology;2024-07

5. Tumor-intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer;Molecular Therapy;2024-07